Vestcor Inc Boosts Stock Holdings in Chemed Corporation $CHE

Vestcor Inc grew its stake in shares of Chemed Corporation (NYSE:CHEFree Report) by 59.4% during the 4th quarter, HoldingsChannel reports. The fund owned 5,689 shares of the company’s stock after buying an additional 2,120 shares during the period. Vestcor Inc’s holdings in Chemed were worth $2,434,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Smartleaf Asset Management LLC lifted its position in shares of Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the fourth quarter worth $27,000. Global Retirement Partners LLC lifted its position in shares of Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after acquiring an additional 58 shares in the last quarter. Rothschild Investment LLC lifted its position in shares of Chemed by 800.0% during the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after acquiring an additional 96 shares in the last quarter. Finally, Danske Bank A S lifted its position in shares of Chemed by 250.0% during the fourth quarter. Danske Bank A S now owns 140 shares of the company’s stock worth $60,000 after acquiring an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Monday. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Oppenheimer decreased their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Finally, Royal Bank Of Canada upped their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $501.50.

Get Our Latest Stock Report on CHE

Chemed Trading Down 0.2%

Chemed stock opened at $440.67 on Monday. The stock has a market cap of $5.85 billion, a P/E ratio of 24.01, a PEG ratio of 1.66 and a beta of 0.54. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $565.66. The firm’s fifty day moving average price is $409.41 and its 200-day moving average price is $424.51. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHEGet Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping the consensus estimate of $5.30 by $0.35. The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts forecast that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio is currently 13.08%.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.33% of the stock is currently owned by corporate insiders.

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.